3alpha,12alpha,22-Trihydroxy-5beta-cholestan-26-oic acid

Metabolite details

Identifier

NKHARVSPBOBBTD-MFZMKPEQSA-N

InChI Key

NKHARVSPBOBBTD-MFZMKPEQSA-N

IUPAC name

(6S)-6-[(3R,5R,8R,9S,10S,12S,13S,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-2-methylheptanoic acid

Preferred name

3alpha,12alpha,22-Trihydroxy-5beta-cholestan-26-oic acid

INN name

—

Synonym

—

ChEBI

CHEBI:186692

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G1_PBS_vs_G2_DSS
• Normal_vs_Neural_Tube_Defect
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d